Entrada Therapeutics, Inc. (20)
Browse by Contract Category
Contracts
-
Stock Purchase Agreement, dated December 7, 2022, by and between Entrada Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated
(Filed With SEC on December 8, 2022)
-
Lease Agreement, dated March 16, 2022 between IDB 17-19 Drydock Limited Partnership and Entrada Therapeutics, Inc
(Filed With SEC on March 22, 2022)
-
Description of Securities of the Registrant
(Filed With SEC on March 15, 2022)
-
Form of Executive Employment Agreement
(Filed With SEC on October 25, 2021)
-
Amended and Restated Strategic Advisory Agreement, by and between the Registrant and Peter S. Kim, to be in effect as of the closing of this offering
(Filed With SEC on October 25, 2021)
-
License Agreement
(Filed With SEC on October 8, 2021)
-
Amended and Restated Employment Agreement, by and between the Registrant and Nathan Dowden, to be in effect as of the closing of this offering
(Filed With SEC on October 25, 2021)
-
Amended and Restated Employment Agreement, by and between the Registrant and Natarajan Sethuraman, to be in effect as of the closing of this offering
(Filed With SEC on October 25, 2021)
-
Amended and Restated Employment Agreement, by and between the Registrant and Dipal Doshi, to be in effect as of the closing of this offering
(Filed With SEC on October 25, 2021)
-
Non-Employee Director Compensation Policy
(Filed With SEC on October 25, 2021)
-
Senior Executive Cash Incentive Bonus Plan
(Filed With SEC on October 25, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its executive officers
(Filed With SEC on October 25, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its directors
(Filed With SEC on October 25, 2021)
-
2021 Employee Stock Purchase Plan
(Filed With SEC on October 25, 2021)
-
2021 Stock Option and Incentive Plan and form of award agreements thereunder
(Filed With SEC on October 25, 2021)
-
Specimen Common Stock Certificate
(Filed With SEC on October 25, 2021)
-
Amended and Restated Investors Rights Agreement among the Registrant and certain of
(Filed With SEC on October 8, 2021)
-
Exclusive License Agreement, by and between the Registrant and OSIF, dated as of December 14, 2018, as amended on October 8, 2019 and further amended on March 9, 2019
(Filed With SEC on October 8, 2021)
-
2016 Stock Incentive Plan, as amended, and form of award agreements thereunder
(Filed With SEC on October 8, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on October 8, 2021)
